Dissertation/Thesis Abstract

RAPIDKardia Diagnostic Incorporated: A Point of Care Testing Company Proposal
by Catbagan, Erico Jay, M.S., California State University, Long Beach, 2019, 72; 13905007
Abstract (Summary)

Approximately every 40 seconds, an American will have a heart attack. Accurate and immediate biomarker testing at the emergency room is an imperative component of the initial diagnosis of patients. Implementation of Point-of-Care testing (POCT) for heart attack biomarkers have shown to improve patient outcome and operational efficiency. RAPIDKardia Diagnostic, Inc. will enter the POCT industry by introducing a device capable of detecting a specific biomarker to diagnose a heart attack. This proposal will outline what is required to begin RAPIDKardia Diagnostic, Inc. and maintain the business through profitability.

Indexing (document details)
Advisor: Gotz, Cindy
Commitee: Gerard, Nathan, Sinay, Tony
School: California State University, Long Beach
Department: Health Care Administration
School Location: United States -- California
Source: MAI 81/3(E), Masters Abstracts International
Subjects: Health care management
Keywords: Acute myocardial infarction, AMI, Cardiac testing, Heart attack, Point of care testing, Troponin
Publication Number: 13905007
ISBN: 9781088337301
Copyright © 2021 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy